Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex Incorporated (NYSE:TFX) will pursue a plan to separate into two new, independent, publicly traded companies: New, ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

What Happened? Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company ...

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex shares tumbled to a 52-week low on Thursday after the medical-technology company posted disappointing financial guidance and unveiled plans for a nearly $800 million acquisition and a spinoff ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

RBC Capital downgraded Teleflex (TFX) to Sector Perform from Outperform with a price target of $155, down from $220. The company reported a Q4 ...

John Deren To Be Named Executive Vice President and Chief Financial Officer ...

Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2024. Fourth quarter financial summary GAAP diluted EPS from continuing ...